SCHEMBL13146493

SCHEMBL13146493

Bc1cnn2c(NCc3ccc(=O)[nH]c3)cc(C3CCCCC3)nc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 6/20 0.52
▸ CDK2 P24941 7/20 0.42
▸ CHEK1 O14757 5/20 0.42
▸ CCNA2 P20248 2/20 0.42
▸ CCNA1 P78396 2/20 0.42
▸ CDK9 P50750 5/20 0.38
▸ CDK5 Q00535 4/20 0.38
▸ CDK1 P06493 4/20 0.38
▸ PDE10A Q9Y233 1/20 0.36
▸ PDE9A O76083 3/20 0.33
▸ CDK7 P50613 4/20 0.33
▸ CCNE1 P24864 3/20 0.33
▸ CCNH P51946 3/20 0.33
▸ MNAT1 P51948 3/20 0.33
▸ GSK3A P49840 2/20 0.32
▸ TAOK1 Q7L7X3 2/20 0.32
▸ CCNT1 O60563 1/20 0.32
▸ CCNT2 O60583 1/20 0.32
▸ BRD4 O60885 1/20 0.32
▸ CCNK O75909 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13305591 0.89 GSK3B (0.52) GSK3BCDK2CHEK1CCNA2CCNA1
SCHEMBL12953224 0.89 GSK3B (0.66) GSK3BCDK2CHEK1CCNA2CCNA1
SCHEMBL13305036 0.81 GSK3B (0.55) GSK3BCDK2CHEK1CCNA2CCNA1
SCHEMBL13304684 0.81 GSK3B (0.49) GSK3BCDK2CHEK1CCNA2CCNA1
SCHEMBL13305112 0.80 CDK2 (0.53) GSK3BCDK2CCNE1
SCHEMBL13304821 0.79 GSK3B (0.53) GSK3BCDK2CHEK1CCNA2CCNA1
SCHEMBL13304869 0.79 GSK3B (0.77) GSK3BCDK2CHEK1CCNE1
SCHEMBL13305061 0.78 GSK3B (0.49) GSK3BCDK2CHEK1CCNA2CCNA1
SCHEMBL13146324 0.74 GSK3B (0.77) GSK3BCDK2CHEK1CCNE1
SCHEMBL13305680 0.74 GSK3B (0.55) GSK3BCDK2CHEK1CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807683-B2 N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors SCHERING CORPORATION (US) 2010-10-05 — — US disclosed
Send feedback